MBIO Mustang Bio, Inc.

NASDAQ
$0.52

Mustang Bio, Inc. (MBIO) is expected to report earnings on November 4, 2026, after the market close.

Mustang Bio Reported Earnings
Wednesday, August 5, 2026 · 12:00 AM ET
Earnings Date
Nov 4
Wednesday · 6:50 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Mustang Bio, Inc.

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.